相似文献
1
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
Clin Pharmacol Ther. 2016 Jun;99(6):585-7. doi: 10.1002/cpt.348. Epub 2016 Feb 19.
2
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
3
[Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):159-65. doi: 10.1007/s00103-014-2095-0.
4
Gut microbiota imbalance and colorectal cancer.
World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501.
5
METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Eksp Klin Gastroenterol. 2016 Jul;12(12):6-29.
6
The resilience of the intestinal microbiota influences health and disease.
Nat Rev Microbiol. 2017 Oct;15(10):630-638. doi: 10.1038/nrmicro.2017.58. Epub 2017 Jun 19.
7
Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Semin Immunol. 2017 Aug;32:3-13. doi: 10.1016/j.smim.2017.04.003. Epub 2017 May 2.
8
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321.
9
Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.
Expert Rev Clin Immunol. 2013 May;9(5):409-22. doi: 10.1586/eci.13.27.
10
A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria.
J Dig Dis. 2015 Aug;16(8):421-30. doi: 10.1111/1751-2980.12274.
引用本文的文献
1
Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer.
Mol Biomed. 2024 Sep 10;5(1):37. doi: 10.1186/s43556-024-00200-3.
2
Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review.
Nutrients. 2019 Aug 12;11(8):1873. doi: 10.3390/nu11081873.
3
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics.
Onco Targets Ther. 2018 Aug 13;11:4797-4810. doi: 10.2147/OTT.S170626. eCollection 2018.
4
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
Gastroenterology. 2017 Feb;152(2):327-339.e4. doi: 10.1053/j.gastro.2016.10.012. Epub 2016 Oct 18.
本文引用的文献
1
Cancer and the microbiota.
Science. 2015 Apr 3;348(6230):80-6. doi: 10.1126/science.aaa4972.
2
Microbial imbalance and intestinal pathologies: connections and contributions.
Dis Model Mech. 2014 Oct;7(10):1131-42. doi: 10.1242/dmm.016428.
3
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis.
J Clin Invest. 2014 Oct;124(10):4166-72. doi: 10.1172/JCI72334. Epub 2014 Aug 8.
4
The microbiome and cancer.
Nat Rev Cancer. 2013 Nov;13(11):800-12. doi: 10.1038/nrc3610. Epub 2013 Oct 17.
5
Escherichia coli induces DNA double-strand breaks in eukaryotic cells.
Science. 2006 Aug 11;313(5788):848-51. doi: 10.1126/science.1127059.
Zotero 插件